Onychomycosis
- PMID: 20347657
- DOI: 10.1016/j.clindermatol.2009.12.006
Onychomycosis
Abstract
Onychomycosis is a frequent nail disease caused by dermatophytes, yeasts, and nondermatophyte molds. Trichophyton rubrum, T mentagrophytes, and Epidermophyton floccosum are the most common etiologic agents worldwide. Candida spp are the most frequent among the yeasts. Diagnosis is corroborated by direct microscopic examination, culture, and histomycology with periodic acid-Schiff stain. Other new methods of diagnosis are discussed. Treatment is based on oral antifungals: terbinafine, itraconazole, and fluconazole, including other emerging triazole drugs. Therapeutic outcome with ciclopirox and amorolfine lacquers alone and combined with systemic therapy are also reviewed, as well as the new nail enhancers and physical and chemical removal of the diseased nails.
Copyright 2010 Elsevier Inc. All rights reserved.
Similar articles
-
An open randomized comparative study to test the efficacy and safety of oral terbinafine pulse as a monotherapy and in combination with topical ciclopirox olamine 8% or topical amorolfine hydrochloride 5% in the treatment of onychomycosis.Indian J Dermatol Venereol Leprol. 2007 Nov-Dec;73(6):393-6. doi: 10.4103/0378-6323.37056. Indian J Dermatol Venereol Leprol. 2007. PMID: 18032857 Clinical Trial.
-
Pharmacoeconomic analysis of ciclopirox nail lacquer solution 8% and the new oral antifungal agents used to treat dermatophyte toe onychomycosis in the United States.J Am Acad Dermatol. 2000 Oct;43(4 Suppl):S81-95. doi: 10.1067/mjd.2000.109069. J Am Acad Dermatol. 2000. PMID: 11051137
-
Itraconazole and terbinafine treatment of some nondermatophyte molds causing onychomycosis of the toes and a review of the literature.J Cutan Med Surg. 2001 May-Jun;5(3):206-10. doi: 10.1007/s102270000019. Epub 2001 May 2. J Cutan Med Surg. 2001. PMID: 11685666 Review.
-
Antifungal Drugs for Onychomycosis: Efficacy, Safety, and Mechanisms of Action.Semin Cutan Med Surg. 2016 Mar;35(3 Suppl 3):S51-5. doi: 10.12788/j.sder.2016.009. Semin Cutan Med Surg. 2016. PMID: 27074700
-
Therapies for the treatment of onychomycosis.Clin Dermatol. 2013 Sep-Oct;31(5):544-54. doi: 10.1016/j.clindermatol.2013.06.011. Clin Dermatol. 2013. PMID: 24079583 Review.
Cited by
-
Gallic acid loaded self-nano emulsifying hydrogel-based drug delivery system against onychomycosis.Nanomedicine (Lond). 2024;19(25):2065-2083. doi: 10.1080/17435889.2024.2386923. Epub 2024 Aug 15. Nanomedicine (Lond). 2024. PMID: 39143900
-
Species distribution and antifungal susceptibility profiles of yeasts isolated from onychomycosis: a cross-sectional study with insights into emerging species.Antonie Van Leeuwenhoek. 2023 Dec 28;117(1):6. doi: 10.1007/s10482-023-01914-0. Antonie Van Leeuwenhoek. 2023. PMID: 38153531
-
In vivo Guinea Pig Model Study for Evaluating Antifungal Effect of a Dual-Diode Laser with Wavelengths of 405 Nm and 635 Nm on Dermatophytosis.Clin Cosmet Investig Dermatol. 2023 Jun 17;16:1559-1567. doi: 10.2147/CCID.S415679. eCollection 2023. Clin Cosmet Investig Dermatol. 2023. PMID: 37351065 Free PMC article.
-
Onychomycosis: Old and New.J Fungi (Basel). 2023 May 12;9(5):559. doi: 10.3390/jof9050559. J Fungi (Basel). 2023. PMID: 37233270 Free PMC article. Review.
-
Quality by Design Guided Development of Polymeric Nanospheres of Terbinafine Hydrochloride for Topical Treatment of Onychomycosis Using a Nano-Gel Formulation.Pharmaceutics. 2022 Oct 12;14(10):2170. doi: 10.3390/pharmaceutics14102170. Pharmaceutics. 2022. PMID: 36297605 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous
